Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKinovo Plc Regulatory News (KINO)

  • This share is currently suspended. It was suspended at a price of 87.00
  • There is currently no data for KINO

No intention to bid statement

19 Sep 2023 12:53

RNS Number : 9549M
Rx3 Holdings Limited
19 September 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF THE UK DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR").

For immediate release

19 September 2023

Rx3 Holdings Limited ("Rx3")

No intention to bid statement

Further to the announcements made by Kinovo plc ("Kinovo") and Rx3 regarding a possible offer to be made for Kinovo by Rx3, Rx3 confirms that it does not intend to make an offer for Kinovo.

As detailed in its announcement on 30 August 2023 (the "Rx3 Announcement"), Rx3 remains concerned over the unresolved and hence open-ended issues that persist with regard to the DCB projects that the Company has stated that it believes will be finalised by the end of 2025 at a cost of £18m with £14m expected to be recovered from clients and subcontractors.

Having not been permitted access to perform due diligence, nor having received a response from the Company seeking to clarify or counter any of the points made in the Rx3 Announcement, this has heightened Rx3's concern and resulted in it deciding not to proceed with any offer. Rx3 will continue to seek further clarity as to the contractual position and the Company's financial exposure regarding the DCB projects. 

Accordingly, except with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel"), Rx3, and any person(s) acting in concert with it, will be bound by the restrictions contained in Rule 2.8 of the Code. Under the provisions of that rule, Rx3 reserves the right to make or participate in an offer for Kinovo (and/or take any other actions which would otherwise be restricted under Rule 2.8 of the Code) within the next six months following the date of this announcement:

(i) with the agreement of the board of directors of Kinovo;

 

(ii) following the announcement of a firm intention to make an offer for Kinovo by or on behalf of a third party;

 

(iii) following the announcement by Kinovo of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Takeover Code) or a reverse takeover (as defined in the Code); or

 

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

 

Enquiries:

Zeus (Financial Adviser to Rx3)

 

+44 (0) 203 829 5000

Dan BateJames Edis

Daniel Phillips

 

 

Further Information

 

Zeus Capital Limited ("Zeus"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser for Rx3 and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Rx3 for providing the protections afforded to clients of Zeus, nor for providing advice in relation to any matter referred to herein.

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of any offer to buy, sell or subscribe for any securities or the solicitation of any vote in any jurisdiction.

 

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPEAFNNFLNDEFA
Date   Source Headline
6th May 20256:14 pmRNSHolding(s) in Company
24th Feb 20253:30 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSExercise of Options and Total Voting Rights
24th Dec 20247:00 amRNSChange of Auditor
26th Nov 20247:00 amRNSInterim Results
7th Nov 20247:00 amRNSTrading Update & Notice of Results
3rd Oct 20247:00 amRNSDCB (Kent) Ltd update
16th Sep 20247:00 amRNSNew direct award contract win of up to £12 million
13th Sep 20247:00 amRNSExternal Audit Tender Process
2nd Sep 20242:44 pmRNSExercise of Options and Total Voting Rights
29th Aug 20247:00 amRNSResult of AGM
20th Aug 20247:00 amRNSSIP, PDMR Shareholding, Exercise of Options & TVR
9th Aug 20247:00 amRNSNew Direct Awards from Framework Agreements
5th Aug 20249:45 amRNSAnnual Report and Notice of AGM
2nd Aug 20247:00 amRNSFinal DCB Project Update
19th Jul 20242:05 pmRNSExercise of Options and Total Voting Rights
16th Jul 20247:00 amRNSAgreement to terminate ninth DCB Project completed
10th Jul 20247:00 amRNSNotice of Investor Presentation
9th Jul 20247:00 amRNSFinal Results
24th May 20247:00 amRNSTrading Update
17th May 20243:50 pmRNSHolding(s) in Company
2nd May 20247:00 amRNSTrading Update
25th Mar 20244:36 pmRNSExercise of Options, PDMR Shareholdings & TVR
11th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSUpdate on DCB Discontinued Operations
9th Feb 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFirst Half Trading Update
26th Sep 20232:30 pmRNSDirector/PDMR Shareholdings
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSStatement regarding Rule 2.8 announcement
19th Sep 202312:53 pmRNSNo intention to bid statement
19th Sep 202311:30 amRNSForm 8.5 (EPT/RI) - Kinovo PLC
15th Sep 202311:43 amRNSForm 8.5 (EPT/RI)
13th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - Neil Rooney
13th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - JTC Employer Solutions
13th Sep 20237:00 amRNSDecarbonisation Direct Award
12th Sep 20236:03 pmRNSForm 8.3 - KINOVO PLC
12th Sep 20233:23 pmRNSForm 8.3 - KINOVO PLC
12th Sep 20239:20 amRNSForm 8.5 (EPT/RI)
8th Sep 20234:30 pmRNSForm 8.3 - Kinovo plc - Fiduchi Trustees Ltd
8th Sep 202311:45 amRNSForm 8 (OPD) - Kinovo plc
8th Sep 20239:55 amRNSForm 8.3 - Kinovo Plc
7th Sep 20236:25 pmRNSForm 8.3 - Kinovo plc
7th Sep 202310:29 amRNSForm 8.3 - Kinovo plc - Amendment
7th Sep 20237:00 amRNSAdditional Framework Wins and Direct Award
5th Sep 20233:30 pmRNSForm 8.3 - Kinovo plc - Michael Whitaker
5th Sep 202311:15 amRNSForm 8.3 - Kinovo plc
5th Sep 20238:34 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.